Lymphoma, T-Cell - 42 Studies Found
| Not yet recruiting |
: Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients : Peripheral T-cell Lymphoma : 2016-06-17 :
|
| Terminated |
: Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 : Peripheral T-Cell Lymphoma : 2013-04-24 : Drug: Brentuximab vedotin Brentuximab vedotin will be given by intravenous infusion (into a vein) on Day |
| Completed |
: Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma : Peripheral T-cell Lymphoma : 2009-03-19 : Drug: PXD101 Belinostat (PXD101) 1000 mg/m²administered as a 30 minute IV infusion on days 1-5 of e |
| Recruiting |
: GDP in Frontline Chemotherapy for Patients With PTCL-NOS : Lymphoma, T-Cell, Peripheral : 2015-03-26 : Drug: GDP chemotherapy gemcitabine (1000mg/m2 intravenously over 30 minutes on days 1 and 8), cisplatin |
| Completed |
: Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma : Peripheral T-cell Lymphoma : 2006-08-14 : Drug: Pralatrexate Injection Pralatrexate 30 mg/m2 via IV push over 3-5 minutes for 6 weeks in a 7 week |
| Recruiting |
: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma : Peripheral T Cell Lymphoma : 2016-10-21 : Drug: Chidamide Chidamide is given to the patients as described, and drug concentration is measured in p |
| Completed |
: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma : Peripheral T-Cell Lymphoma : 2011-07-18 : Biological: denileukin diftitox (E7777) E7777 will be administered by intravenous (IV) infusion for 5 da |
| Active, not recruiting |
: Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry : Peripheral T-cell Lymphoma : 2010-04-23 |
| Not yet recruiting |
: Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma : Peripheral T Cell Lymphoma : 2016-07-24 : Drug: Chidamide with ICE regimen Chidamide and ICE regimen, dosage described in arm description |
| Recruiting |
: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma : Peripheral T Cell Lymphoma : 2016-04-19 : Drug: Chidamide |